Although the American Society of Clinical Oncology (ASCO) 2010 guidelines recommend that ER and PR assays be considered positive if at least 1% of tumor nuclei are positive in the sample being tested[7], earlier studies have used a 10% cutoff. This evidence concerns the gene PGR and neoplasm.